These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 26125210)

  • 1. Hidradenitis suppurativa and concomitant pyoderma gangrenosum treated With infliximab.
    Groleau PF; Grossberg AL; Gaspari AA
    Cutis; 2015 Jun; 95(6):337-42. PubMed ID: 26125210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
    Reddick CL; Singh MN; Chalmers RJ
    Dermatol Online J; 2010 Aug; 16(8):15. PubMed ID: 20804692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyoderma gangrenosum associated with hidradenitis suppurativa.
    Ah-Weng A; Langtry JA; Velangi S; Evans CD; Douglas WS
    Clin Exp Dermatol; 2005 Nov; 30(6):669-71. PubMed ID: 16197385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pyoderma gangrenosum associated with hidradenitis suppurativa: a case report and review of the literature].
    García-Rabasco AE; Esteve-Martínez A; Zaragoza-Ninet V; Sánchez-Carazo JL; Alegre-de-Miquel V
    Actas Dermosifiliogr; 2010 Oct; 101(8):717-21. PubMed ID: 20965015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy.
    Bruzzese V
    J Clin Rheumatol; 2012 Dec; 18(8):413-5. PubMed ID: 23188209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyoderma gangrenosum and concomitant hidradenitis suppurativa--rapid response to canakinumab (anti-IL-1β).
    Jaeger T; Andres C; Grosber M; Zirbs M; Hein R; Ring J; Traidl-Hoffmann C
    Eur J Dermatol; 2013; 23(3):408-10. PubMed ID: 23816498
    [No Abstract]   [Full Text] [Related]  

  • 7. Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review.
    Hsiao JL; Antaya RJ; Berger T; Maurer T; Shinkai K; Leslie KS
    Arch Dermatol; 2010 Nov; 146(11):1265-70. PubMed ID: 21079064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases.
    Moschella SL
    Int J Dermatol; 2007 Dec; 46(12):1287-91. PubMed ID: 18173525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent hidradenitis suppurativa, inflammatory acne, dissecting cellulitis of the scalp, and pyoderma gangrenosum in a 16-year-old boy.
    Koshelev MV; Garrison PA; Wright TS
    Pediatr Dermatol; 2014; 31(1):e20-1. PubMed ID: 24118007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of hidradenitis suppurativa with infliximab in a patient who failed to respond to etanercept.
    Poulin Y
    J Cutan Med Surg; 2009; 13(4):221-5. PubMed ID: 19706231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen.
    Shenefelt PD
    Cutis; 1996 May; 57(5):315-9. PubMed ID: 8726710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases.
    Trent JT; Kerdel FA
    Dermatol Nurs; 2005 Apr; 17(2):97-107. PubMed ID: 15916184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
    Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
    Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome.
    Stichweh DS; Punaro M; Pascual V
    Pediatr Dermatol; 2005; 22(3):262-5. PubMed ID: 15916580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
    Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P
    Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of diseases associated with pyoderma gangrenosum and correlation with effectiveness of therapy: New insights on the diagnosis and therapy of comorbid hidradenitis suppurativa.
    Fischer AH; Jourabchi N; Khalifian S; Lazarus GS
    Wound Repair Regen; 2022 May; 30(3):338-344. PubMed ID: 35385180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL; Lowe L; Kang S
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne.
    Vinkel C; Thomsen SF
    Int J Dermatol; 2017 Aug; 56(8):811-818. PubMed ID: 28345207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-psoriatic dermatologic uses of monoclonal antibody therapy.
    Sockolov ME; Alikhan A; Zargari O
    J Dermatolog Treat; 2009; 20(6):319-27. PubMed ID: 19954387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infliximab for a girl with refractory pyoderma gangrenosum].
    Nozawa T; Hara R; Kinoshita J; Sano F; Miyamae T; Imagawa T; Mori M; Hirokado M; Takahashi K; Inayama Y; Yokota S
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Dec; 31(6):454-9. PubMed ID: 19122376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.